139 
because I really believe that sooner or later there are going to be other 
hazards singled out by the biological community for assessment, and they 
might in fact even be real hazards that are singled out. 
(Laughter. ) 
I think there should be a way in which a mechanism by which these can 
be brought to the attention and treated in a jury type fashion. I wish to 
point out to you that neither at Asilomar nor at the meetings of this NIH 
committee has there ever been a hearing of testimony. No one has ever in- 
vited me to come and give my two cents in a testimony- type fashion. I have 
been invited to meetings to sit on the outside, and there is always this 
self-serving thing which continually is a troublesome problem for all of us 
working in the area who want to have our opinions known. 
But I really think that there is a future to this type of regulation 
which you ought to address yourself to. How can this committee really 
point out, really have a truly objective way of assessing this hazard 
and future hazards? 
Now, what else do I want to say? I have probably run out of time. 
DR. FREDRICKSON: Yes, you have, almost. 
DR. BROWN: I am sorry. Well, maybe I can answer questions, then, 
rather than haranguing further. 
DR. FREDRICKSON: I gather from your statement that you had some 
specific objections and recommendations, and the committee will have 
those before them. 
DR. BROWN: Well, you will see on this typewritten thing that the 
last two pages deal with — are entitled "Specific Objections to and 
Recommendations for the NIH Guidelines." 
DR. FREDRICKSON: Right. 
DR. BROVIN: These deal with my major objections. Some are fairly 
technical which I will be glad to answer if you would like me to. 
Features such as purifying DNA 99 percent pure. I doubt that any member 
of the committee can tell me how that can be done and judged. I would 
like to hear a member of the committee tell me. You might as well just 
say they are banned. 
DR. FREDRICKSON: Dr. Singer? 
DR. SINGER: Oh, I am sorry, I was waiting for your call for comments. 
[280] 
